Bank Of America Corp Bristol Myers Squibb CO Put Options Transaction History

Bank Of America Corp

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $12.6 Million - $16.4 Million	-316,600 Reduced 42.42%	429,700 $22.2 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $7.46 Million - $9.82 Million	185,400 Added 33.05%	746,300 $31 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $8.08 Million - $9.16 Million	168,400 Added 42.9%	560,900 $30.4 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $1.09 Million - $1.3 Million	22,500 Added 6.08%	392,500 $20.1 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $14.6 Million - $16.2 Million	-228,400 Reduced 38.17%	370,000 $23.7 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $16.3 Million - $18.5 Million	-248,400 Reduced 29.33%	598,400 $41.5 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $19.9 Million - $23.5 Million	-290,300 Reduced 25.53%	846,800 $60.9 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $50,037 - $29.6 Million	384,900 Added 51.17%	1,137,100 $80.8 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $2.14 Million - $2.35 Million	-29,400 Reduced 3.76%	752,200 $57.9 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $25.6 Million - $30.7 Million	415,800 Added 113.67%	781,600 $57.1 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $93.1 Million - $108 Million	-1,735,100 Reduced 82.59%	365,800 $22.8 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $103 Million - $120 Million	1,735,300 Added 474.64%	2,100,900 $124 Million
Q2 2021 Sep 13, 2021	BUY	$61.91 - $67.42 $22.6 Million - $24.6 Million	365,600 New	365,600 $24.4 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.